Coronary revascularization in multivessel disease Which is better, stents or surgery?

被引:0
|
作者
Almeda, Francis Q. [1 ,2 ]
Snell, R. Jeffrey [2 ,3 ]
机构
[1] Ingalls Mem Hosp, Cardiol Sect, Harvey, IL 60426 USA
[2] Rush Univ, Rush Med Coll, Chicago, IL 60612 USA
[3] Rush Univ, Med Ctr, Rush Heart Inst, Intervent Cardiol Fellowship Program, Chicago, IL 60612 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary artery disease (CAD) remains the major cardiovascular health issue in contemporary clinical practice. Treatment options for multivessel CAD include medical therapy, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG). Here, the authors review the most recent data that compare intracoronary stenting to CABG in multivessel disease. They address therapeutic issues surrounding proper selection of the optimal revascularization strategy and give special consideration to high-risk populations, such as patients with diabetes.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [1] Percutaneous revascularization of multivessel coronary disease using stents -: a multicenter, prospective study
    Baldus, S
    Köster, R
    Küchler, R
    von Dahl, J
    Dietz, U
    Voelker, W
    Reimers, J
    Kuck, KH
    Sasse, A
    Rupprecht, JH
    Sieburg, B
    Meyer, J
    Berger, J
    Meinertz, T
    Hamm, CW
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (11) : 547 - 552
  • [2] Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease
    Bangalore, Sripal
    Guo, Yu
    Samadashvili, Zaza
    Blecker, Saul
    Xu, Jinfeng
    Hannan, Edward L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13): : 1213 - 1222
  • [3] Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery
    Bangalore, Sripal
    Guo, Yu
    Samadashvili, Zaza
    Blecker, Saul
    Xu, Jinfeng
    Hannan, Edward L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (11) : 1209 - 1220
  • [4] Revascularization for Coronary Artery Disease: Stents Versus Bypass Surgery
    King, Spencer B., III
    Marshall, John Jeffrey
    Tummala, Pradyumna E.
    ANNUAL REVIEW OF MEDICINE, 2010, 61 : 199 - 213
  • [5] Drug-coated balloons: A better revascularization strategy in patients with multivessel coronary artery disease undergoing one-stop hybrid coronary revascularization surgery
    Fu, Yuan
    Gao, Jie
    Zuo, Kun
    Hua, Cuncun
    Yang, Yixing
    Liu, Xinming
    Xu, Li
    Lu, Changlin
    Su, Pixiong
    Zhang, Dapeng
    KARDIOLOGIA POLSKA, 2023, 81 (11) : 1122 - 1129
  • [6] Hybrid coronary revascularization for multivessel coronary artery disease
    Hu, Shengshou
    Gao, Runlin
    CORONARY ARTERY DISEASE, 2014, 25 (03) : 258 - 265
  • [7] What is the preferred strategy for revascularization of patients with multivessel disease: Percutaneous coronary intervention with drug-eluting stents or coronary artery bypass surgery?
    Javaid, Aamir
    Buch, Ashesh N.
    Xue, Zhenyi
    Corso, Paul F.
    Satler, Lowell F.
    Kent, Kenneth M.
    Pichard, Augusto D.
    Pichard, Augusto D.
    Waksman, Ron
    CIRCULATION, 2006, 114 (18) : 434 - 434
  • [8] Completeness of revascularization in multivessel coronary artery disease
    Sandoval, Yader
    Brilakis, Emmanouil S.
    Garcia, Santiago
    JOURNAL OF THORACIC DISEASE, 2016, 8 (11) : E1493 - E1496
  • [9] Drug-eluting stents versus bypass surgery for multivessel coronary disease
    Kutcher M.A.
    Current Cardiovascular Risk Reports, 2009, 3 (5) : 331 - 338
  • [10] Hybrid revascularization in multivessel coronary artery disease
    Repossini, Alberto
    Tespili, Maurizio
    Saino, Antonio
    Kotelnikov, Igor
    Moggi, Annalisa
    Di Bacco, Lorenzo
    Muneretto, Claudio
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 44 (02) : 288 - 294